Javid Moslehi

Education And Training Johns Hopkins University, Baltimore, MD BA 06/1996 Biology University of Connecticut, Farmington, CT MD 06/2001 Medicine Johns Hopkins Hospital, Baltimore, MD 06/2004 Residency, Internal Medicine Brigham and Women's Hospital, Boston, MA 06/2007 Fellowship, Cardiology Dana-Farber Cancer Institute, Boston, MA 05/2014 Post-Doctoral Fellowship, Oncology Awards And Honors Brigham and Women's Hospital, Harvard Medical School 2009 Thomas Smith Award in Heart Failure Research Stanley J. Sarnoff Cardiovascular Research Foundation 2016 Alumni Achievement Award Vanderbilt University 2016 Biomedical Science Impact Award American Society of Clinical Investigation (ASCI) 2020 Elected Member UCSF 2021 Inaugural Holder of the William Grossman Distinguished Professorship in Cardiology Overview CLINICAL INTERESTS: Cardio-Oncology, Cardio-Immunology RESEARCH INTERESTS: I am a cardiologist and myocyte biologist. My clinical focus is cardio-oncology and cardio-immunology. My clinical interests overlap with my laboratory focus, where we are investigating the mechanistic underpinnings of cardiovascular sequelae of novel targeted and immune-based cancer therapies. Since 2016, a major focus of my clinical and research program has been the interaction between the cardiovascular and immune systems. Our group initially described a novel clinical syndrome of fulminant myocarditis that arises from (ICI) immune checkpoint inhibitors (Johnson et al, NEJM, 2016). We further defined the clinical characteristics of ICI-associated myocarditis (Moslehi et al, Lancet, 2018) and showed that cardiovascular sequelae of ICI include pericarditis, vasculitis and arrhythmias (Salem et al, Lancet Oncology, 2018).